Lead optimization of 5-amino-6-(2,2-dimethyl-5-oxo-4-phenylpiperazin-1-yl)-4-hydroxyhexanamides to reduce a cardiac safety issue: Discovery of DS-8108b, an orally active renin inhibitor
2013
Nakamura, Yuji | Fujimoto, Teppei | Ogawa, Yasuyuki | Namiki, Hidenori | Suzuki, Sayaka | Asano, Masayoshi | Sugita, Chie | Mochizuki, Akiyoshi | Miyazaki, Shojiro | Tamaki, Kazuhiko | Nagai, Yōko | Inoue, Shin-ichi | Nagayama, Takahiro | Katō, Mikio | Chiba, Katsuyoshi | Takasuna, Kiyoshi | Nishi, Takahide
With the aim to address an undesired cardiac issue observed with our related compound in the recently disclosed novel series of renin inhibitors, further chemical modifications of this series were performed. Extensive structure–activity relationships studies as well as in vivo cardiac studies using the electrophysiology rat model led to the discovery of clinical candidate trans-adamantan-1-ol analogue 56 (DS-8108b) as a potent renin inhibitor with reduced potential cardiac risk. Oral administration of single doses of 3 and 10mg/kg of 56 in cynomolgus monkeys pre-treated with furosemide led to significant reduction of mean arterial blood pressure for more than 12h.
Show more [+] Less [-]AGROVOC Keywords
Bibliographic information
This bibliographic record has been provided by National Agricultural Library